Reference Libraries

December 11, 2015

DEVELOPMENT OF A COMBINATION MICROBICIDE GEL FORMULATION CONTAINING IQP-0528 AND TENOFOVIR FOR THE PREVENTION OF HIV INFECTION.

In light of the increasing worldwide AIDS pandemic, there is a continuing need to develop new prevention strategies to inhibit the transmission of HIV-1. In the absence of a successful vaccine, topical microbicides represent the best strategies to reduce the... Read More

December 11, 2015

AN IN VITRO MODEL OF HUMAN AIRWAY EPITHELIUM (EPIAIRWAY) FOR IN VITRO METABOLISM, TOXICITY SCREENING AND DRUG DELIVERY APPLICATIONS.

This study by MatTek Corp. scientists demonstrated that the EpiAirway in vitro human tracheal/bronchial tissue equivalent possesses the in vivo-like physical and biochemical attributes necessary for evaluating the delivery of drugs, metabolism, airway irritation, and toxicity potential of environmental/occupational chemicals.... Read More

December 11, 2015

DEVELOPMENT OF AN IN VITRO ALTERNATIVE ASSAY METHOD FOR VAGINAL IRRITATION.

The vaginal mucosa is commonly exposed to chemicals and therapeutic agents that may result in irritation and/or inflammation. In addition to acute effects, vaginal irritation and inflammation can make women more susceptible to infections such as HIV-1 and herpes simplex... Read More

December 11, 2015

HUMAN VAGINAL—ECTOCERVIAL TISSUE MODEL TO TEST THE IRRITATION POTENTIAL OF CONTRACEPTIVE AND VAGINAL-CARE PRODUCTS.

December 11, 2015

Reference Libraries

DEVELOPMENT OF A COMBINATION MICROBICIDE GEL FORMULATION CONTAINING IQP-0528 AND TENOFOVIR FOR THE PREVENTION OF HIV INFECTION.

AN IN VITRO MODEL OF HUMAN AIRWAY EPITHELIUM (EPIAIRWAY) FOR IN VITRO METABOLISM, TOXICITY SCREENING AND DRUG DELIVERY APPLICATIONS.

DEVELOPMENT OF AN IN VITRO ALTERNATIVE ASSAY METHOD FOR VAGINAL IRRITATION.

HUMAN VAGINAL—ECTOCERVIAL TISSUE MODEL TO TEST THE IRRITATION POTENTIAL OF CONTRACEPTIVE AND VAGINAL-CARE PRODUCTS.

PRE-VALIDATION OF RECONSTRUCTED EPIVAGINAL TISSUE MODEL TO SCREEN IRRITATION POTENTIAL OF CHEMICALS.

Get the latest